Advertisement
Advertisement

ENTX

ENTX logo

Entera Bio Ltd. Ordinary Shares

1.41
USD
Sponsored
-0.05
-3.77%
Jan 30, 13:10 UTC -5
Open

ENTX Earnings Reports

Positive Surprise Ratio

ENTX beat 21 of 28 last estimates.

75%

Next Report

Date of Next Report
Mar 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.09
Implied change from Q3 25 (Revenue/ EPS)
--
/
+28.57%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+50.00%

Entera Bio Ltd. Ordinary Shares earnings per share and revenue

On Nov 14, 2025, ENTX reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 23.75% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -1.11% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an increase of 28.57% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Entera Bio Ltd. Ordinary Shares reported EPS of -$0.07, beating estimates by 23.75%, and revenue of --, -- -- expectations.
The stock price moved down -1.11%, changed from $2.71 before the earnings release to $2.68 the day after.
The next earning report is scheduled for Mar 26, 2026.
Based on 3 analysts, Entera Bio Ltd. Ordinary Shares is expected to report EPS of -$0.09 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement